Colossal Biosciences founder Ben Lamm discusses his company's efforts to bring back extinct species, including the woolly ...

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

De-extinction startup Colossal Biosciences is discussing raising additional funds that would value the company at $20B or ...

Colossal Biosciences isn't taking on this task alone. It's working with a network of collaborators from zoos and museums.

A Texas biotech company is trying to bring mammoths and other extinct creatures back to life. The science is as intriguing as the ethical... Colossal Biosciences breeds controversy while trying to ...

Add Yahoo as a preferred source to see more of our stories on Google. Just more than a week has gone by since Colossal Biosciences, the company seeking to bring back the woolly mammoth, revealed it ...

After 225 years extinct, scientists have sequenced DNA and edited cells to move the bluebuck closer to a return. Colossal Biosciences adds extinct bluebuck antelope to its de-extinction project ...

So, what's the deal with this mega-project? Colossal Biosciences, known for its groundbreaking de-extinction efforts (it has even planned for the return of mammoths!), is investing substantial funds ...

De-extinction startup Colossal Biosciences is reportedly seeking new capital, aiming for a valuation between $20 billion and ...

Colossal Biosciences is celebrating a huge victory. The Texas-based biotechnology and engineering company successfully managed to de-extinct the dire wolf, a canine species that went extinct thousands ...

Colossal Biosciences is pulling one final surprise out of its hat in 2025. Announced today, the company’s nonprofit arm—The Colossal Foundation—secured an additional $50 million in funding, doubling ...